Home β€Ί Stock analysis β€Ί MDT

Medtronic (MDT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

MDT dips 0.7% to $94.75. Closed at $94.75, -0.73% vs the prior close of $95.45. Day range $94.26–$96.49, opened at $95.83.

Last close$94.75-0.73%
Day range94.26–96.49
Open95.83
Volume29.74M
52-week range73.31–106.33
Avg volume (20d)33.84M

MDT daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” MDT dips 0.7% to $94.75
Oct 15, 2026 β€” MDT rises 1.3% to $95.45, a 6-month high on 2.9x normal volume
Oct 14, 2026 β€” MDT rises 1.3% to $94.23, a 6-month high on 3.1x normal volume
Oct 13, 2026 β€” MDT rises 1.2% to $93.01, 4 up days in a row
Oct 12, 2026 β€” MDT jumps 3.9% to $91.93 on 2.4x normal volume
Oct 9, 2026 β€” MDT rises 0.8% to $88.48 on 2.7x normal volume
Oct 8, 2026 β€” MDT rises 2.6% to $87.75 on 8.3x normal volume
Oct 7, 2026 β€” MDT dips 1.8% to $85.51, a 1-month low on 4.7x normal volume
Oct 6, 2026 β€” MDT dips 1.0% to $87.09 on 4.8x normal volume
Oct 5, 2026 β€” MDT rises 1.8% to $87.97 on 4.3x normal volume
Oct 2, 2026 β€” MDT ends flat (-0.1%) to $86.38 on 3.7x normal volume

MDT latest news & SEC filings

Every SEC filing by or about MDT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 16, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001984186-26-000010

Oct 16, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001560409-26-000011

Oct 16, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001999371-26-022971

Oct 16, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001999371-26-022968

Oct 15, 2026 Β· Form 144 β€” Planned insider sale

Notice of proposed sale (Form 144) β€” an insider or affiliate plans to sell restricted or control shares

A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.

Source: SEC EDGAR filing 0001959173-26-007405

Oct 15, 2026 Β· Form 144 β€” Planned insider sale

Notice of proposed sale (Form 144) β€” an insider or affiliate plans to sell restricted or control shares

A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.

Source: SEC EDGAR filing 0001959173-26-007377

Oct 14, 2026 Β· Form SC TO-I/A β€” SC TO-I/A filing

SC TO-I/A filing

Source: SEC EDGAR filing 0001628280-26-065823

Oct 14, 2026 Β· Form 425 β€” 425 filing

425 filing

Source: SEC EDGAR filing 0001628280-26-065819

Oct 13, 2026 Β· Form SC TO-I/A β€” SC TO-I/A filing

SC TO-I/A filing

Source: SEC EDGAR filing 0001628280-26-065599

Oct 13, 2026 Β· Form 425 β€” 425 filing

425 filing

Source: SEC EDGAR filing 0001628280-26-065596

Oct 9, 2026 Β· Form 425 β€” 425 filing

425 filing

Source: SEC EDGAR filing 0001628280-26-065550

Oct 8, 2026 Β· Form 425 β€” 425 filing

425 filing

Source: SEC EDGAR filing 0001628280-26-065465

Oct 8, 2026 Β· Form SC TO-I/A β€” SC TO-I/A filing

SC TO-I/A filing

Source: SEC EDGAR filing 0001628280-26-065406

Oct 8, 2026 Β· Form 425 β€” 425 filing

425 filing

Source: SEC EDGAR filing 0001628280-26-065402

Oct 8, 2026 Β· Form 425 β€” 425 filing

425 filing

Source: SEC EDGAR filing 0001628280-26-065361

Things to know before you trade MDT

MDT market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 202695.8396.4994.2694.7529.74M
Oct 15, 202695.0096.2493.9695.4550.23M
Oct 14, 202693.0194.7292.1694.2349.86M
Oct 13, 202692.3593.0190.2093.0124.93M
Oct 12, 202690.7692.8790.7191.9336.56M
Oct 9, 202688.4989.8187.4088.4838.86M
Oct 8, 202685.9088.4885.5587.75105.66M
Oct 7, 202687.4088.1985.4385.5155.89M
Oct 6, 202687.9788.5086.4587.0952.13M
Oct 5, 202686.3388.1285.5387.9743.69M
Oct 2, 202686.5587.9485.5986.3835.36M
Oct 1, 202685.8586.8485.2286.4429.28M
Sep 30, 202686.5787.4286.2086.2926.61M
Sep 29, 202688.8389.2286.3887.0919.45M
Sep 28, 202688.3289.5387.5289.5022.55M
Sep 25, 202687.6188.9987.1288.6413.05M
Sep 24, 202689.7490.2888.4688.5110.96M
Sep 23, 202690.5391.1588.6189.3010.53M
Sep 22, 202692.5192.6790.5590.7714.06M
Sep 21, 202691.5092.7391.5091.757.31M

About Medtronic

Medtronic (MDT) is listed on the NYSE and classified by the SEC under β€œElectromedical & Electrotherapeutic Apparatus”. Its business address is in GALWAY. Fiscal year ends April 24. SEC CIK 1613103.

MDT board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Craig ArnoldDirectorApr 29, 2026
Scott C DonnellyDirectorApr 29, 2026
Lidia FonsecaDirectorApr 29, 2026
John P GroetelaarsDirectorApr 29, 2026
Randall J HoganDirectorApr 29, 2026
William R JellisonDirectorApr 29, 2026
Joon Sup LeeDirectorApr 29, 2026
Gregory P LewisDirectorApr 29, 2026
Kevin E LoftonDirectorApr 29, 2026
Geoffrey MarthaChairman and CEOAug 4, 2026
Elizabeth G NabelDirectorApr 29, 2026
Kendall J PowellDirectorApr 29, 2026

Executive officers

NameTitleLatest filing
Denise L. BlomquistChief Accounting OfficerSep 16, 2026
Harry Skip KiilEVP & President CardiovascularSep 17, 2026
Michael MarinaroEVP, Pres MedSurg and AmericasAug 24, 2026
Geoffrey MarthaChairman and CEOAug 4, 2026
Thierry PietonEVP & Chief Financial OfficerAug 4, 2026
Michelle QuinnEVP, GC and SecretaryAug 4, 2026
Gregory L SmithEVP Global Ops & Supply ChainNov 21, 2025
Kweli ThompsonEVP & President, NeuroscienceAug 4, 2026
Brett A. WallEVP & Pres NeuroscienceMay 28, 2026
Matthew R. WalterSVP, Chief HR OfficerAug 4, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Sep 16, 2026Harry Skip KiilSale1,483$93.65
Sep 16, 2026Harry Skip KiilSale1,483$93.65
Sep 16, 2026Harry Skip KiilSale1,483$93.65
Sep 16, 2026Harry Skip KiilSale1,483$93.65
Jul 8, 2026Matthew R. WalterSale3,102$83.15
Jul 8, 2026Matthew R. WalterSale3,102$83.15
Jul 8, 2026Matthew R. WalterSale3,102$83.15
Jul 8, 2026Matthew R. WalterSale3,102$83.15
Jun 8, 2026Harry Skip KiilSale228$80.45
Jun 8, 2026Harry Skip KiilSale3,961$80.44
Jun 8, 2026Harry Skip KiilSale228$80.45
Jun 8, 2026Harry Skip KiilSale3,961$80.44
Jun 8, 2026Harry Skip KiilSale228$80.45
Jun 8, 2026Harry Skip KiilSale3,961$80.44
Jun 8, 2026Harry Skip KiilSale228$80.45

MDT financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Apr 24, 2026$36.36B$4.80B3.73$7.33B
Apr 25, 2025$33.54B$4.66B3.61$7.04B
Apr 26, 2024$32.36B$3.68B2.76$6.79B
Apr 28, 2023$31.23B$3.76B2.82$6.04B
Apr 29, 2022$31.69B$5.04B3.73$7.35B

Latest balance sheet: total assets $93.31B, total liabilities $42.46B, cash $1.69B (as of Jul 31, 2026).

MDT earnings / results-day log

DateFilingClose that day
Sep 1, 20268-K Item 2.02 (results)$92.04
Jun 3, 20268-K Item 2.02 (results)$77.95
Feb 17, 20268-K Item 2.02 (results)$96.41
Nov 18, 20258-K Item 2.02 (results)$100.80
Aug 19, 20258-K Item 2.02 (results)$89.90
May 21, 20258-K Item 2.02 (results)$84.41
Feb 18, 20258-K Item 2.02 (results)$86.07
Nov 19, 20248-K Item 2.02 (results)$85.00
Aug 20, 20248-K Item 2.02 (results)β€”
May 23, 20248-K Item 2.02 (results)β€”
Feb 20, 20248-K Item 2.02 (results)β€”
Nov 21, 20238-K Item 2.02 (results)β€”

Related stocks Β· Electromedical & Electrotherapeutic Apparatus

Integer (ITGR)TransMedics (TMDX)Axogen (AXGN)LivaNova (LIVN)Nexalin Technology (NXL)Conmed (CNMD)Ceribell (CBLL)InMode (INMD)Electromed (ELMD)Hyperfine (HYPR)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on MDT

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.